HIV Gene Therapy

Somatic Cell Gene Therapy of HIV Infection Explored

Published in AIDS Weekly, December 4th, 1995

Somatic cell gene therapy has the potential to delay the onset of AIDS in HIV infected patients.

Recent research has shown that the onset of AIDS is directly related to the extent of HIV replication in the host. Any treatment which significantly inhibits HIV replication has the potential to delay progression to AIDS.

French researchers, Vincent Vieillard et al., explored the possibility of utilizing the multiple antiviral activities of interferon-(beta) (IFN-(beta)) in a somatic cell gene therapy protocol against HIV infection ("Autocrine Interferon-(beta) Synthesis for Gene Therapy of HIV Infection: Increased Resistance to HIV-1 in Lymphocytes...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1995-12-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry